Company

Corvidane

Pharmaceutical Manufacturing United States 3 employees ENTO

Employees: 3

bbncardio.com LinkedIn

Corvidane Overview

Headquarters: United States
Website: bbncardio.com
Industry: Pharmaceutical Manufacturing
Employees: 3
Founded: 2014
Stock Symbol: ENTO
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

IT Consulting

About Corvidane

Corvidane is developing Corvida™ to treat TWO formidable diseases. Corvidane uses a novel approach to treat metabolic and inflammatory diseases. Corvida(TM) for Atherosclerosis - In development to be a Best-in-Class, orally administered adjunct to lipid regulating therapies (Statins/PCSK9) that targets atherosclerotic plaques, the major factor in Heart Attacks and Stroke. Corvida(TM) for MASH - In development to be a Best-in-Class, orally administered drug to treat MASH, which is the leading cause of liver transplants in the United States.